Laura A. Smith, MPH, RD, Ciara H. O’Flanagan, PhD, Laura W

Slides:



Advertisements
Similar presentations
Chapter 22 Energy balance Metabolism Homeostatic control of metabolism
Advertisements

Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Endocrine System 2. Part 2: Metabolism Overweight or obesity Adiposity Central obesity B.M.I. above normal Body fat greater than normal Abnormal distribution.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
GYN ONCOLOGY OBesity Project. “Obesity is linked as a cause of 20% of cancer deaths in women.”
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
NUTRITION AND CANCER: BEFORE, DURING AND AFTER Andrew D. Nish MD.
LOW CARB, HIGH FAT ECON 4 LIN THOMPSON. KETOGENIC DIETS < 100 CARBOHYDRATES PER DAY ADKINS IS THE BEST KNOWN KETOGENIC DIET PUTS THE BODY IN KETOSIS.
STRUCTURE;TYPES; AND FUNCTION
Endocrine Block 1 Lecture Dr. Usman Ghani
Chapter 7 Metabolic syndrome
Endocrine Block | Dr. Usman Ghani
Riva Touger-Decker, PhD, RD, FADA, Connie Mobley, PhD, RD 
Obesity Dr. Sumbul Fatma.
Endocrine Block 1 Lecture Dr. Usman Ghani
Valerie Schulz, MMSc, RD, LD/N, CDE
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Intermyocellular fat depot
Brown Fat-Derived Exosomes: Small Vesicles with Big Impact
Volume 14, Issue 2, Pages (August 2011)
Acne: The Role of Medical Nutrition Therapy
Volume 47, Issue 3, Pages (September 2017)
Vascular biology of metabolic syndrome
Diet, Obesity, and Chronic Disease
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
White adipose tissue (HFD)
NAFLD, Obesity, and Bariatric Surgery
Volume 18, Issue 4, Pages (October 2013)
Mechanisms of Obesity-Induced Gastrointestinal Neoplasia
Fishing Out a Sensor for Anti-inflammatory Oils
BAT Thermogenesis: Linking Shivering to Exercise
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and Pancreas  Edward Giovannucci, Dominique Michaud  Gastroenterology 
Figure 1 Simplified representation of the physiological
Central Nervous System Mechanisms Linking the Consumption of Palatable High-Fat Diets to the Defense of Greater Adiposity  Karen K. Ryan, Stephen C. Woods,
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Playtime Prevents Obesity by Brain-Mediated Fat Browning
Volume 3, Issue 3, Pages (March 2006)
Chad M. Trent, Martin J. Blaser  Cell Metabolism 
Obesity, Inflammation, and Insulin Resistance
Adiponectin, Resistin and Leptin Response to Dietary Intervention in Diabetic Nephropathy  Lucyna Kozłowska, PhD, Andrzej Rydzewski, MD, PhD, Bartosz.
IKKɛ: A Bridge between Obesity and Inflammation
Diet or Exercise Interventions vs Combined Behavioral Weight Management Programs: A Systematic Review and Meta-Analysis of Direct Comparisons  David J.
Metabolic triggered inflammation in osteoarthritis
Volume 18, Issue 4, Pages (October 2013)
NRG4: An Endocrine Link between Brown Adipose Tissue and Liver
Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era  Faustino R. Pérez-López,
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Figure 2 Mechanisms of crosstalk between adipocytes and the kidney
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
Volume 140, Issue 6, Pages (March 2010)
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Jieun Lee, Joseph Choi, Susanna Scafidi, Michael J. Wolfgang 
Fishing Out a Sensor for Anti-inflammatory Oils
Volume 24, Issue 20, Pages R988-R993 (October 2014)
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Fat Distribution & Physiology
Volume 14, Issue 2, Pages (August 2011)
Renin–angiotensin system blockade and diabetes: moving the adipose organ from the periphery to the center  Oliver Lenz, Alessia Fornoni  Kidney International 
Volume 72, Issue 11, Pages (December 2007)
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Treating Diabetes by Blocking a Vascular Growth Factor
Macrophages, Immunity, and Metabolic Disease
Adipose tissue, adipokines, and inflammation
Volume 76, Issue 2, Pages (July 2009)
Joshua D. Eikenberg, Brenda M. Davy, PhD, RD 
Presentation transcript:

Translating Mechanism-Based Strategies to Break the Obesity−Cancer Link: A Narrative Review  Laura A. Smith, MPH, RD, Ciara H. O’Flanagan, PhD, Laura W. Bowers, PhD, RD, Emma H. Allott, PhD, Stephen D. Hursting, PhD, MPH  Journal of the Academy of Nutrition and Dietetics  Volume 118, Issue 4, Pages 652-667 (April 2018) DOI: 10.1016/j.jand.2017.08.112 Copyright © 2018 Academy of Nutrition and Dietetics Terms and Conditions

Figure 1 Obesity is associated with increased risk of developing and dying from the following cancers: breast (in postmenopausal women), ovarian, liver, gallbladder, kidney (renal cell), colon, pancreatic, gastric, esophageal (adenocarcinoma), endometrial, thyroid, multiple myeloma, and meningioma. In addition, obesity is associated with progression (but not incidence) of prostate cancer. Journal of the Academy of Nutrition and Dietetics 2018 118, 652-667DOI: (10.1016/j.jand.2017.08.112) Copyright © 2018 Academy of Nutrition and Dietetics Terms and Conditions

Figure 2 Expansion of adipose tissue depots characteristic of obesity results in many metabolic disturbances including altered systemic metabolism and increased growth factor, inflammatory and angiogenic signaling. These obesity-associated perturbations foster a microenvironment favorable for tumorigenesis, facilitating many of the hallmarks of cancer and increasing disease risk and progression. IGF-1=insulin-like growth factor; PAI-1=plasminogen activator inhibitor-1; PI3K=phospatidylinositol-3 kinase; VEGF=vascular endothelial growth factor. Journal of the Academy of Nutrition and Dietetics 2018 118, 652-667DOI: (10.1016/j.jand.2017.08.112) Copyright © 2018 Academy of Nutrition and Dietetics Terms and Conditions

Figure 3 The human body contains two types of adipocytes: white adipocytes (which have a unilocular lipid droplet) and brown adipocytes (which have many small lipid droplets). When engorged with triglyceride, white adipocytes secrete a number of factors that promote growth factor signaling and inflammation including leptin, resistin, insulin-like growth factor (IGF)-1, free fatty acids, tumor necrosis factor−α (TNF-α), and interleukin-6. In addition, they reduce production of anti-inflammatory adiponectin. Brown adipocytes secrete several factors involved in thermogenesis, decreased inflammation, normalized insulin sensitivity, and/or increased energy expenditure, such as adiponectin, bone morphogenetic proteins, neuregulin-4, lactate, triiodothyronine, retinaldehyde, and fibroblast growth factor (FGF)-21. IGF-1=insulin-like growth factor−1; PAI-1=plasminogen activator inhibitor-1. Journal of the Academy of Nutrition and Dietetics 2018 118, 652-667DOI: (10.1016/j.jand.2017.08.112) Copyright © 2018 Academy of Nutrition and Dietetics Terms and Conditions

Figure 4 Reductions in adiposity and weight attained from dietary interventions including caloric restriction (CR), intermittent fasting (IF), low-fat diet (LFD), and ketogenic diet (KD), have been shown to reduce adiposity and inversely modulate many of the same cancer risk biomarkers that are impacted by obesity and excess adiposity. Obesity-associated systemic alterations are reduced through these dietary interventions, resulting in decreased circulating glucose, growth factor signaling, inflammation, and angiogenesis, attenuating cancer risk and progression. Metabolic alterations of CR and IF interventions have been associated with reduced cancer risk and progression. KD has not been linked to cancer risk in humans; however, it has been demonstrated that adherence to KD reduces cancer risk and progression in preclinical studies. Evidence is mixed concerning implementation of an LFD, exhibiting little to no reduction in cancer risk and progression. AMPK=adenosine monophosphate−activated protein kinase; PAI-1=plasminogen activator inhibitor-1; PI3K=phospatidylinositol-3 kinase; VEGF=vascular endothelial growth factor. Journal of the Academy of Nutrition and Dietetics 2018 118, 652-667DOI: (10.1016/j.jand.2017.08.112) Copyright © 2018 Academy of Nutrition and Dietetics Terms and Conditions